# Cintas Corp: financial statements, quarterly

CTAS · Nasdaq · CIK 723254 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends May 31

Pages: [Overview](/companies/ctas.md) · [Financials](/companies/ctas/financials.md) · [Filings](/companies/ctas/filings.md) · [Insiders](/companies/ctas/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ctas/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,377](/filings/0000723254-25-000003.md) | [2,406](/filings/0001628280-25-016483.md) | [2,471 d](/filings/0000723254-26-000028.md) | [2,502](/filings/0000723254-25-000033.md) | [2,562](/filings/0000723254-26-000002.md) | [2,609](/filings/0000723254-26-000012.md) | [2,668 d](/filings/0000723254-26-000028.md) | [2,718](/filings/0000723254-26-000047.md) | [2,800](/filings/0000723254-26-000002.md) | [2,841](/filings/0000723254-26-000012.md) | [2,905 d](/filings/0000723254-26-000028.md) | [3,014](/filings/0000723254-26-000047.md) |
| Cost of revenue | $m | not reported | not reported | not reported | [1,249](/filings/0000723254-25-000033.md) | [1,285](/filings/0000723254-26-000002.md) | [1,290](/filings/0000723254-26-000012.md) | [1,342 d](/filings/0000723254-26-000028.md) | [1,352](/filings/0000723254-26-000047.md) | [1,388](/filings/0000723254-26-000002.md) | [1,393](/filings/0000723254-26-000012.md) | [1,425 d](/filings/0000723254-26-000028.md) | [1,460](/filings/0000723254-26-000047.md) |
| Gross profit | $m | not reported | not reported | not reported | [1,252](/filings/0000723254-25-000033.md) | [1,277](/filings/0000723254-26-000002.md) | [1,319](/filings/0000723254-26-000012.md) | [1,326 d](/filings/0000723254-26-000028.md) | [1,367](/filings/0000723254-26-000047.md) | [1,412](/filings/0000723254-26-000002.md) | [1,448](/filings/0000723254-26-000012.md) | [1,480 d](/filings/0000723254-26-000028.md) | [1,554](/filings/0000723254-26-000047.md) |
| Selling, general and administrative | $m | [642](/filings/0000723254-25-000003.md) | [667](/filings/0001628280-25-016483.md) | [668 d](/filings/0000723254-26-000028.md) | [691](/filings/0000723254-25-000033.md) | [685](/filings/0000723254-26-000002.md) | [709](/filings/0000723254-26-000012.md) | [729 d](/filings/0000723254-26-000028.md) | [749](/filings/0000723254-26-000047.md) | [757](/filings/0000723254-26-000002.md) | [789](/filings/0000723254-26-000012.md) | [792 d](/filings/0000723254-26-000028.md) | [827](/filings/0000723254-26-000047.md) |
| Operating income | $m | [500](/filings/0000723254-25-000003.md) | [521](/filings/0001628280-25-016483.md) | [548 d](/filings/0000723254-26-000028.md) | [561](/filings/0000723254-25-000033.md) | [591](/filings/0000723254-26-000002.md) | [610](/filings/0000723254-26-000012.md) | [597 d](/filings/0000723254-26-000028.md) | [618](/filings/0000723254-26-000047.md) | [656](/filings/0000723254-26-000002.md) | [660](/filings/0000723254-26-000012.md) | [673 d](/filings/0000723254-26-000028.md) | [712](/filings/0000723254-26-000047.md) |
| Interest expense | $m | [26.6](/filings/0000723254-24-000005.md) | [25.5](/filings/0000723254-24-000018.md) | [24.1 d](/filings/0000723254-26-000028.md) | [25.6](/filings/0000723254-25-000033.md) | [26.7](/filings/0000723254-26-000002.md) | [24.8](/filings/0000723254-26-000012.md) | [24.1 d](/filings/0000723254-26-000028.md) | [24.2](/filings/0000723254-26-000047.md) | [28.1](/filings/0000723254-26-000002.md) | [28.2](/filings/0000723254-26-000012.md) | [25.8 d](/filings/0000723254-26-000028.md) | [24.7](/filings/0000723254-26-000047.md) |
| Income tax | $m | [99.2](/filings/0000723254-25-000003.md) | [98.6](/filings/0001628280-25-016483.md) | [113 d](/filings/0000723254-26-000028.md) | [84.6](/filings/0000723254-25-000033.md) | [117](/filings/0000723254-26-000002.md) | [123](/filings/0000723254-26-000012.md) | [127 d](/filings/0000723254-26-000028.md) | [105](/filings/0000723254-26-000047.md) | [133](/filings/0000723254-26-000002.md) | [130](/filings/0000723254-26-000012.md) | [137 d](/filings/0000723254-26-000028.md) | [138](/filings/0000723254-26-000047.md) |
| Net income | $m | [375](/filings/0001628280-25-016483.md) | [398](/filings/0001628280-25-016483.md) | [414 d](/filings/0000723254-26-000028.md) | [452](/filings/0000723254-26-000012.md) | [448](/filings/0000723254-26-000012.md) | [463](/filings/0000723254-26-000012.md) | [448 d](/filings/0000723254-26-000028.md) | [491](/filings/0000723254-26-000047.md) | [495](/filings/0000723254-26-000012.md) | [502](/filings/0000723254-26-000012.md) | [511 d](/filings/0000723254-26-000028.md) | [552](/filings/0000723254-26-000047.md) |
| Diluted EPS | $ per share | [0.90](/filings/0000723254-25-000003.md) | [0.96](/filings/0001628280-25-016483.md) | not reported | [1.10](/filings/0000723254-25-000033.md) | [1.09](/filings/0000723254-26-000002.md) | [1.13](/filings/0000723254-26-000012.md) | not reported | [1.20](/filings/0000723254-26-000047.md) | [1.21](/filings/0000723254-26-000002.md) | [1.24](/filings/0000723254-26-000012.md) | not reported | [1.36](/filings/0000723254-26-000047.md) |
| Basic EPS | $ per share | [0.92](/filings/0000723254-25-000003.md) | [0.98](/filings/0001628280-25-016483.md) | not reported | [1.12](/filings/0000723254-25-000033.md) | [1.11](/filings/0000723254-26-000002.md) | [1.14](/filings/0000723254-26-000012.md) | not reported | [1.21](/filings/0000723254-26-000047.md) | [1.23](/filings/0000723254-26-000002.md) | [1.25](/filings/0000723254-26-000012.md) | not reported | [1.37](/filings/0000723254-26-000047.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000723254-24-000005.md) | [0.1](/filings/0000723254-24-000018.md) | [0.3](/filings/0000723254-25-000017.md) | [0.1](/filings/0000723254-24-000053.md) | [0.1](/filings/0000723254-25-000003.md) | [0.2](/filings/0001628280-25-016483.md) | [0.3](/filings/0000723254-26-000028.md) | [0.1](/filings/0000723254-25-000033.md) | [0.2](/filings/0000723254-26-000002.md) | [0.2](/filings/0000723254-26-000012.md) | [0.3](/filings/0000723254-26-000047.md) | [0.2](/filings/0000723254-26-000047.md) |
| Current assets | $bn | [3.0](/filings/0000723254-24-000005.md) | [3.0](/filings/0000723254-24-000018.md) | [3.2](/filings/0000723254-25-000017.md) | [3.0](/filings/0000723254-24-000053.md) | [3.2](/filings/0000723254-25-000003.md) | [3.3](/filings/0001628280-25-016483.md) | [3.4](/filings/0000723254-26-000028.md) | [3.4](/filings/0000723254-25-000033.md) | [3.5](/filings/0000723254-26-000002.md) | [3.6](/filings/0000723254-26-000012.md) | [3.9](/filings/0000723254-26-000047.md) | [3.9](/filings/0000723254-26-000047.md) |
| Total assets | $bn | [8.8](/filings/0000723254-25-000003.md) | [9.0](/filings/0001628280-25-016483.md) | [9.2](/filings/0000723254-26-000028.md) | [9.1](/filings/0000723254-25-000033.md) | [9.4](/filings/0000723254-26-000002.md) | [9.6](/filings/0000723254-26-000012.md) | [9.8](/filings/0000723254-26-000028.md) | [9.8](/filings/0000723254-26-000047.md) | [10.1](/filings/0000723254-26-000002.md) | [10.2](/filings/0000723254-26-000012.md) | [10.5](/filings/0000723254-26-000047.md) | [10.7](/filings/0000723254-26-000047.md) |
| Current liabilities | $bn | [1.4](/filings/0000723254-24-000005.md) | [1.3](/filings/0000723254-24-000018.md) | [1.8](/filings/0000723254-25-000017.md) | [2.0](/filings/0000723254-24-000053.md) | [2.0](/filings/0000723254-25-000003.md) | [1.9](/filings/0001628280-25-016483.md) | [1.6](/filings/0000723254-26-000028.md) | [1.5](/filings/0000723254-25-000033.md) | [2.1](/filings/0000723254-26-000002.md) | [1.8](/filings/0000723254-26-000012.md) | [2.7](/filings/0000723254-26-000047.md) | [2.7](/filings/0000723254-26-000047.md) |
| Long-term debt | $bn | [2.5](/filings/0000723254-24-000005.md) | [2.5](/filings/0000723254-24-000018.md) | [2.0](/filings/0000723254-25-000017.md) | [2.0](/filings/0000723254-24-000053.md) | [2.0](/filings/0000723254-25-000003.md) | [2.0](/filings/0001628280-25-016483.md) | [2.4](/filings/0000723254-26-000028.md) | [2.4](/filings/0000723254-25-000033.md) | [2.4](/filings/0000723254-26-000002.md) | [2.4](/filings/0000723254-26-000012.md) | [1.4](/filings/0000723254-26-000047.md) | [1.4](/filings/0000723254-26-000047.md) |
| Current portion of debt | $bn | [0.2](/filings/0000723254-24-000005.md) | not reported | [0.4](/filings/0000723254-25-000017.md) | [0.6](/filings/0000723254-24-000053.md) | [0.6](/filings/0000723254-25-000003.md) | [0.4](/filings/0001628280-25-016483.md) | [0.0](/filings/0000723254-26-000028.md) | not reported | [0.6](/filings/0000723254-26-000002.md) | [0.2](/filings/0000723254-26-000012.md) | [1.0](/filings/0000723254-26-000047.md) | [1.0](/filings/0000723254-26-000047.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.0](/filings/0001628280-25-016483.md) | [4.2](/filings/0001628280-25-016483.md) | [4.3](/filings/0000723254-26-000028.md) | [4.0](/filings/0000723254-26-000012.md) | [4.3](/filings/0000723254-26-000012.md) | [4.6](/filings/0000723254-26-000012.md) | [4.7](/filings/0000723254-26-000047.md) | [4.8](/filings/0000723254-26-000047.md) | [4.5](/filings/0000723254-26-000012.md) | [4.8](/filings/0000723254-26-000012.md) | [5.1](/filings/0000723254-26-000047.md) | [5.2](/filings/0000723254-26-000047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [393 d](/filings/0000723254-25-000003.md) | [657 d](/filings/0001628280-25-016483.md) | [682 d](/filings/0000723254-26-000028.md) | [460](/filings/0000723254-25-000033.md) | [445 d](/filings/0000723254-26-000002.md) | [620 d](/filings/0000723254-26-000012.md) | [640 d](/filings/0000723254-26-000028.md) | [414](/filings/0000723254-26-000047.md) | [531 d](/filings/0000723254-26-000002.md) | [621 d](/filings/0000723254-26-000012.md) | [709 d](/filings/0000723254-26-000028.md) | [572](/filings/0000723254-26-000047.md) |
| Capital expenditure | $m | [93.8 d](/filings/0000723254-25-000003.md) | [107 d](/filings/0001628280-25-016483.md) | [102 d](/filings/0000723254-26-000028.md) | [92.9](/filings/0000723254-25-000033.md) | [101 d](/filings/0000723254-26-000002.md) | [99.9 d](/filings/0000723254-26-000012.md) | [115 d](/filings/0000723254-26-000028.md) | [102](/filings/0000723254-26-000047.md) | [106 d](/filings/0000723254-26-000002.md) | [90.9 d](/filings/0000723254-26-000012.md) | [96.0 d](/filings/0000723254-26-000028.md) | [108](/filings/0000723254-26-000047.md) |
| Dividends paid | $m | [138 d](/filings/0000723254-25-000003.md) | [137 d](/filings/0001628280-25-016483.md) | [138 d](/filings/0000723254-26-000028.md) | [138](/filings/0000723254-25-000033.md) | [157 d](/filings/0000723254-26-000002.md) | [158 d](/filings/0000723254-26-000012.md) | [158 d](/filings/0000723254-26-000028.md) | [158](/filings/0000723254-26-000047.md) | [182 d](/filings/0000723254-26-000002.md) | [181 d](/filings/0000723254-26-000012.md) | [181 d](/filings/0000723254-26-000028.md) | [181](/filings/0000723254-26-000047.md) |
| Share repurchases | $m | [350 d](/filings/0000723254-25-000003.md) | [45.0 d](/filings/0001628280-25-016483.md) | [232 d](/filings/0000723254-26-000028.md) | [615](/filings/0000723254-25-000033.md) | [36.7 d](/filings/0000723254-26-000002.md) | [26.6 d](/filings/0000723254-26-000012.md) | [257 d](/filings/0000723254-26-000028.md) | [266](/filings/0000723254-26-000047.md) | [636 d](/filings/0000723254-26-000002.md) | [31.6 d](/filings/0000723254-26-000012.md) | [18.9 d](/filings/0000723254-26-000028.md) | [316](/filings/0000723254-26-000047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-11-30) | Q3 FY2023 (2023-02-28) | Q1 FY2024 (2023-08-31) | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [103](/filings/0000723254-24-000005.md) | [103](/filings/0000723254-24-000018.md) | [414](/filings/0000723254-24-000053.md) | [413](/filings/0000723254-25-000003.md) | [413](/filings/0001628280-25-016483.md) | [410](/filings/0000723254-25-000033.md) | [411](/filings/0000723254-26-000002.md) | [410](/filings/0000723254-26-000012.md) | [409](/filings/0000723254-26-000047.md) | [406](/filings/0000723254-26-000002.md) | [405](/filings/0000723254-26-000012.md) | [404](/filings/0000723254-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 397,075,093 at 2026-09-30, from the cover of the [10-Q filed 2026-10-07](/filings/0000723254-26-000047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.